NCT03955250

Brief Summary

The overall aim of this program of research is to refine and test the feasibility and acceptability of a newly developed mobile device-delivered app, called Mobile After-Care Support (MACS), to improve patients' coping and treatment adherence following a hospitalization related to their psychotic-spectrum disorder. The purpose of the proposed project is to establish the feasibility, acceptability, and preliminary effects of the app. To achieve the specific aims, the investigators will conduct a pilot randomized clinical trial (n = 60), with two treatment arms: MACS vs. a mobile app attention control condition.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 16, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 20, 2019

Completed
11 days until next milestone

Study Start

First participant enrolled

May 31, 2019

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2022

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

August 2, 2023

Completed
Last Updated

March 19, 2024

Status Verified

February 1, 2024

Enrollment Period

3 years

First QC Date

May 16, 2019

Results QC Date

July 31, 2023

Last Update Submit

February 19, 2024

Conditions

Keywords

schizophreniapsychosismHealthpsychiatric hospitalizationtreatment adherencetransitions of carecoping skillspsychosocial intervention

Outcome Measures

Primary Outcomes (1)

  • Client Satisfaction Questionnaire (CSQ)

    The Client Satisfaction Questionnaire is a self-report measure of patient satisfaction with treatment. The total score (sum of items) will be used and ranges from 8 to 32 with increased scores indicating greater satisfaction with treatment.

    1 month

Secondary Outcomes (3)

  • Brief Psychiatric Rating Scale (BPRS)

    Baseline, 4 month

  • Brief Adherence Rating Scale (BARS)

    Baseline, 4 month

  • Brief Cope Inventory (Brief COPE)

    Baseline, 4 month

Study Arms (2)

Mobile After-Care Support (MACS) app

EXPERIMENTAL

All participants download the app to their mobile phone. The app runs through a third-party software platform. It is designed to provide ecological momentary assessment and intervention.

Behavioral: Mobile After-Care Support (MACS) app

Mobile app attention control

ACTIVE COMPARATOR

All participants download the app to their mobile phone. The app runs through a third-party software platform. It is designed to provide ecological momentary assessment and psychoeducation about illness.

Behavioral: Mobile app attention control

Interventions

The MACS app assesses and intervenes by fostering increased treatment adherence (medication/appointments) and self-coping with illness (active, planned, problem-solving focused) to reduce symptoms and improve functioning.

Mobile After-Care Support (MACS) app

The control app provides ecological momentary assessment and psychoeducation about illness.

Mobile app attention control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • recently hospitalized
  • DSM-5 criteria for psychotic-spectrum disorder based on structured clinical interview
  • years or older
  • prescribed antipsychotic medication upon discharge
  • ability to speak and read English

You may not qualify if:

  • substance use disorders at severe level
  • planned discharge to supervised living setting or participation in formal outpatient adherence programs
  • pregnancy or other medical condition contraindicating use of antipsychotic medications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Butler Hospital

Providence, Rhode Island, 02916, United States

Location

Related Publications (1)

  • Gaudiano BA, Ward M, Benz MB, Hughes C, Johnson JE, Moitra E. Feasibility and acceptability of a mobile intervention for patients with psychosis following psychiatric hospitalization: A pilot randomized controlled trial. Psychol Serv. 2025 May;22(2):221-231. doi: 10.1037/ser0000869. Epub 2024 Jun 6.

MeSH Terms

Conditions

Psychotic DisordersSchizophreniaTreatment Adherence and Compliance

Interventions

Amyloid

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental DisordersHealth BehaviorBehavior

Intervention Hierarchy (Ancestors)

Multiprotein ComplexesMacromolecular SubstancesProteinsAmino Acids, Peptides, and Proteins

Limitations and Caveats

This was a pilot RCT and therefore was designed to assess feasibility and acceptability of the intervention in preparation for a larger clinical trial. It was not powered to test comparative efficacy.

Results Point of Contact

Title
Brandon Gaudiano, Ph.D.
Organization
Butler Hospital

Study Officials

  • Brandon Gaudiano, PhD

    Butler Hospital

    PRINCIPAL INVESTIGATOR
  • Ethan Moitra, PhD

    Brown University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 16, 2019

First Posted

May 20, 2019

Study Start

May 31, 2019

Primary Completion

May 31, 2022

Study Completion

May 31, 2022

Last Updated

March 19, 2024

Results First Posted

August 2, 2023

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will share

Uploaded to NIMH Data Archive

Locations